← Back to Dashboard

Atazanavir

Protease inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(…
AXRYRYVKAWYZBR-GASGPIRDSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus3

FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDAJapanRussia
Approval ref: AntiviralDbApproval ref (kegg.jp) Approval ref (pmda.go.jp)
Human immunodeficiency virus 1
HIV-1
Target: Viral protease
FDA approved
Preclinical
Phase 2
Phase 3
Approved
FDAJapanRussia
Approval ref (kegg.jp) Approval ref (pmda.go.jp) DB01072
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
JapanRussia
Approval ref (kegg.jp) Approval ref (pmda.go.jp) PMID:32759267